Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

ClinicalTrials.gov ID: NCT00107731

Public ClinicalTrials.gov record NCT00107731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 1:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Parallel-Group, Double-Blind, Phase 3 Comparison of the Efficacy & Safety of Quetiapine Fumarate to Placebo When Used as Adjunct to Mood Stabilizers (Lithium or Valproate) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients (Abbreviated)

Study identification

NCT ID
NCT00107731
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
710 participants

Conditions and interventions

Interventions

  • divalproex Drug
  • lithium Drug
  • quetiapine fumarate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2004
Primary completion
Not listed
Completion
Sep 30, 2006
Last update posted
Mar 24, 2009

2004 – 2006

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Research Site Birmingham Alabama
Research Site Beverly Hills California
Research Site Chula Vista California
Research Site Redlands California
Research Site San Francisco California
Research Site Santa Ana California
Research Site Gainesville Florida
Research Site Jacksonville Florida
Research Site Miami Florida
Research Site Sarasota Florida
Research Site Tampa Florida
Research Site Winter Park Florida
Research Site Granite City Illinois
Research Site Libertyville Illinois
Research Site Schaumburg Illinois
Research Site Wichita Kansas
Research Site Metairie Louisiana
Research Site Glen Burnie Maryland
Research Site Kalamazoo Michigan
Research Site Saint Charles Missouri
Research Site St Louis Missouri
Research Site Brooklyn New York
Research Site Olean New York
Research Site Rochester New York
Research Site Morganton North Carolina
Research Site Raleigh North Carolina
Research Site Oklahoma City Oklahoma
Research Site Portland Oregon
Research Site Havertown Pennsylvania
Research Site Media Pennsylvania
Research Site Philadelphia Pennsylvania
Research Site Conroe Texas
Research Site Houston Texas
Research Site Richmond Virginia
Research Site Seattle Washington
Research Site Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 130 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00107731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2009 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00107731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →